pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
2,216
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Marketed
vandetanib
Caprelsa (vandetanib)
Medullary Thyroid Cancer
Genzyme Corp
19
catalysts
Marketed
rifapentine
Priftin (rifapentine)
Pulmonary Tuberculosis
Sanofi-Aventis US LLC
17
catalysts
Marketed
TRAVOPROST
TRAVOPROST (TRAVOPROST)
Ocular Hypertension
Sandoz Inc
11
catalysts
Marketed
← prev
page 13 of 74
next →
131
Pain
89
Neurology
1
propranolol hydrochloride ER
Propranolol Hydrochloride (propranolol hydrochloride)
Angina (Angina Pectoris)
Par Pharmaceutical Inc
1
catalysts
Marketed
DIFLUPREDNATE
DIFLUPREDNATE (DIFLUPREDNATE)
Ocular Pain (Eye Pain)
Glucocorticoid receptor
Ocuvex Therapeutics Inc
11
catalysts
Marketed
budesonide DR
Tarpeyo (budesonide)
IgA Nephropathy (Berger's Disease)
Calliditas Therapeutics AB
4
catalysts
Marketed
BETAMETHASONE DIPROPIONATE
BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE)
Inflammation
Perrigo New York Inc
1
catalysts
Marketed
CHLORPROMAZINE HYDROCHLORIDE
CHLORPROMAZINE HYDROCHLORIDE (CHLORPROMAZINE HYDROCHLORIDE)
Tetanus
Fosun Pharma USA Inc
1
catalysts
Marketed
CUPRIC CHLORIDE
CUPRIC CHLORIDE (CUPRIC CHLORIDE)
$AMRX
Amneal Pharmaceuticals, Inc.
1
catalysts
Marketed
folic acid
Quiofic (folic acid [INN])
Megaloblastic Anemia
CMP Pharma Inc
1
catalysts
Marketed
paliperidone ER
Paliperidone (paliperidone)
Schizoaffective Disorder
Eskayef Pharmaceuticals Ltd
1
catalysts
Marketed
insulin human
Afrezza (insulin human)
Type 1 Diabetes (Juvenile Diabetes)
Insulin receptor
$MNKD
MANNKIND CORP
14
catalysts
Marketed
EPYSQLI
EPYSQLI (ECULIZUMAB-AAGH)
Samsung Bioepis Co Ltd
10
catalysts
Marketed
suzetrigine
Journavx (suzetrigine)
Diabetic Peripheral Neuropathy
$VERX
Vertex, Inc.
2
catalysts
Marketed
METHADONE HYDROCHLORIDE
METHADONE HYDROCHLORIDE (METHADONE HYDROCHLORIDE)
Pain
Aurolife Pharma LLC
343
catalysts
Marketed
zilucoplan
Zilbrysq (zilucoplan)
Myasthenia Gravis
UCB SA
6
catalysts
Marketed
Ketorolac Tromethamine Apotex
Ketorolac Tromethamine (ketorolac tromethamine)
Allergic Conjunctivitis
Apotex Corp
5
catalysts
Marketed
ACYCLOVIR
ACYCLOVIR (ACYCLOVIR)
Genital Herpes
Yiling Pharmaceutical Ltd
3
catalysts
Marketed
BUPRENORPHINE HYDROCHLORIDE
BUPRENORPHINE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE)
Pain
BioDelivery Sciences International Inc
270
catalysts
Marketed
FENOFIBRATE
FENOFIBRATE (FENOFIBRATE)
Hypercholesterolemia
Orit Laboratories LLC
19
catalysts
Marketed
TYENNE
TYENNE (TOCILIZUMAB-AAZG)
Fresenius Kabi USA LLC
8
catalysts
Marketed
AVTOZMA
AVTOZMA (TOCILIZUMAB-ANOH)
Celltrion Inc
4
catalysts
Marketed
ganciclovir
Zirgan (ganciclovir)
Herpetic Keratitis
$BLCO
Bausch & Lomb Corp
5
catalysts
Marketed
SITAGLIPTIN PHOSPHATE
SITAGLIPTIN PHOSPHATE (SITAGLIPTIN PHOSPHATE)
Type 2 Diabetes
Merck Sharp & Dohme LLC
3
catalysts
Marketed
SACUBITRIL AND VALSARTAN
SACUBITRIL AND VALSARTAN (SACUBITRIL)
Somerset Therapeutics LLC
1
catalysts
Marketed
etonogestrel CR
Nexplanon (etonogestrel)
Female Contraception
$DARE
Dare Bioscience, Inc.
19
catalysts
Marketed
lecanemab
Leqembi Iqlik (lecanemab-irmb)
Alzheimer's Disease
Amyloid-beta precursor protein
Eisai Co Ltd
8
catalysts
Marketed
ublituximab
Briumvi (ublituximab)
Relapsing Multiple Sclerosis (RMS)
$TGTX
TG THERAPEUTICS, INC.
5
catalysts
Marketed
OTULFI
OTULFI (USTEKINUMAB-AAUZ)
Fresenius Kabi USA LLC
9
catalysts
Marketed
belumosudil mesylate
Rezurock (belumosudil mesylate)
Graft Versus Host Disease (GVHD)
Kadmon Pharmaceuticals LLC
5
catalysts
